Agenus Inc.
Anti-TIM-3 antibodies and methods of use thereof

Last updated:

Abstract:

The instant disclosure provides antibodies that specifically bind to TIM-3 (e.g., human TIM-3) and antagonize TIM-3 function. Also provided are pharmaceutical compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies, and methods of treating a subject using these antibodies.

Status:
Grant
Type:

Utility

Filling date:

2 Mar 2020

Issue date:

9 Feb 2021